Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study

Autor: Cambursano, Victor H, Fernandez, Marcelo J, Scherbovsky, Fernando D, Yanez, Anahi, Tolcachier, Alberto J, Stok, Ana M, Verra, Fernando J B, Korn, Stephanie, Forster, Karin, Rolke, Mathias, Ludwig-Sengpiel, Andrea, Schmoller, Tibor, Schmidt, Olaf, Milger-Kneidinger, Katrin, Hoffmann, Martin, Temme, Hilke, Linnhoff, Anneliese, Welte, Tobias, Kirschner, Joachim, Kuna, Piotr, Rewerska, Barbara, Pisarczyk-Bogacka, Ewa, Haak Lee, Sang, Jae Lee, Byung, Park, Heung-Woo, Park, Jung-Won, Young Lee, Sook, Sook Cho, You, Ho Lee, Kwan, Bavbek, Sevim, Gemicioglu, Bilun, Ediger, Dane, Koca Kalkan, Ilkay, Hanta, Ismail, Yorgancioglu, Arzu, DytyatkovsKa, Yevgeniya, Mostovoy, Yuriy M, Lebed, Kyrylo, Yakovenko, Oleh, Bernstein, David I, Tillinghast, Jeffrey P, Que, Loretta, Madison, Jan, Rambasek, Todd, Shenoy, Kartik, Thompson, Charles A, Chappel, Christopher M, Hudes, Golda, Sorial, Ehab, Kureishy, Shahrukh A, Rehman, Syed M, Lugogo, Njira, Gonzalez, Erika G, Umeh, Fred C, Boren, Eric J, Sigmon, Jason, Ismail, Hummayun, Mohan, Arjun, Bansal, Sandeep, Kaelin, Thomas D, Wechsler, Michael E *, Menzies-Gow, Andrew, Brightling, Christopher E, Griffiths, Janet M, Sałapa, Kinga, Hellqvist, Åsa, Almqvist, Gun, Lal, Harbans, Kaur, Primal, Skärby, Tor, Colice, Gene
Zdroj: In The Lancet Respiratory Medicine July 2022 10(7):650-660
Databáze: ScienceDirect